These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37120136)

  • 1. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
    Majhail NS; Miller B; Dean R; Manghani R; Shin H; Sivaraman S; Maziarz RT
    Transplant Cell Ther; 2023 Dec; 29(12):749.e1-749.e5. PubMed ID: 37703995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
    Lin C; Sajeev G; Stiff PJ; Brunstein CG; Cutler C; Sanz G; Lindemans CA; Rezvani AR; Hanna R; Koh LP; Maziarz RT; Hwang WYK; Song Y; Liu Q; Manghani R; Sivaraman S; Signorovitch J; Horwitz ME; Sung AD
    Transplant Cell Ther; 2023 Jan; 29(1):52.e1-52.e9. PubMed ID: 36179986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation.
    de Koning C; Tao W; Lacna A; van Veghel K; Horwitz ME; Sanz G; Jagasia MH; Wagner JE; Stiff PJ; Hanna R; Cilloni D; Valcárcel D; Peled T; Galamidi Cohen E; Goshen U; Pandit A; Lindemans CA; Jan Boelens J; Nierkens S
    Bone Marrow Transplant; 2021 Nov; 56(11):2826-2833. PubMed ID: 34312498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
    Bejanyan N; Brunstein CG; Cao Q; Lazaryan A; Luo X; Curtsinger J; Mehta RS; Warlick E; Cooley SA; Blazar BR; Miller JS; Weisdorf D; Wagner JE; Verneris MR
    Blood Adv; 2018 Apr; 2(8):909-922. PubMed ID: 29678809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients.
    De Sa H; Maziarz RT; Gandhi AP
    Expert Opin Biol Ther; 2024 Mar; 24(3):139-146. PubMed ID: 38481366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
    Khera N; Edwards ML; Song Y; Sun R; Manghani R; Shin H; Simantov R; Signorovitch J; Sivaraman S; Gergis U
    Adv Ther; 2024 Apr; 41(4):1637-1651. PubMed ID: 38427220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
    Parikh S; Brochstein JA; Galamidi E; Schwarzbach A; Kurtzberg J
    Blood Adv; 2021 Feb; 5(3):843-852. PubMed ID: 33560399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
    Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
    Horwitz ME; Stiff PJ; Cutler C; Brunstein C; Hanna R; Maziarz RT; Rezvani AR; Karris NA; McGuirk J; Valcarcel D; Schiller GJ; Lindemans CA; Hwang WYK; Koh LP; Keating A; Khaled Y; Hamerschlak N; Frankfurt O; Peled T; Segalovich I; Blackwell B; Wease S; Freedman LS; Galamidi-Cohen E; Sanz G
    Blood; 2021 Oct; 138(16):1429-1440. PubMed ID: 34157093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
    Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
    Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
    Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
    Front Immunol; 2018; 9():1841. PubMed ID: 30154788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recovery and the role of recent thymic emigrated T lymphocytes after pediatric hematopoietic stem cell transplantation.
    Justus JLP; Beltrame MP; de Azambuja AP; Schluga YC; Martins EA; Rocha MTL; Rodrigues AM; Loth G; Lima ACM; Bonfim C
    Cytotherapy; 2024 Sep; 26(9):980-987. PubMed ID: 38762804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Infections and Delayed CD4
    Khimani F; Ranspach P; Elmariah H; Kim J; Whiting J; Nishihori T; Locke FL; Perez Perez A; Dean E; Mishra A; Perez L; Lazaryan A; Jain MD; Nieder M; Liu H; Faramand R; Hansen D; Alsina M; Ochoa L; Davila M; Anasetti C; Pidala J; Bejanyan N
    Transplant Cell Ther; 2021 Nov; 27(11):940-948. PubMed ID: 34329754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation.
    van Roessel I; Prockop S; Klein E; Boulad F; Scaradavou A; Spitzer B; Kung A; Curran K; O'Reilly RJ; Kernan NA; Cancio M; Boelens JJ
    Cytotherapy; 2020 Sep; 22(9):503-510. PubMed ID: 32622752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
    Ballen KK; Joffe S; Brazauskas R; Wang Z; Aljurf MD; Akpek G; Dandoy C; Frangoul HA; Freytes CO; Khera N; Lazarus HM; LeMaistre CF; Mehta P; Parsons SK; Szwajcer D; Ustun C; Wood WA; Majhail NS
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1819-27. PubMed ID: 25064747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
    Lin C; Schwarzbach A; Sanz J; Montesinos P; Stiff P; Parikh S; Brunstein C; Cutler C; Lindemans CA; Hanna R; Koh LP; Jagasia MH; Valcarcel D; Maziarz RT; Keating AK; Hwang WYK; Rezvani AR; Karras NA; Fernandes JF; Rocha V; Badell I; Ram R; Schiller GJ; Volodin L; Walters MC; Hamerschlak N; Cilloni D; Frankfurt O; McGuirk JP; Kurtzberg J; Sanz G; Simantov R; Horwitz ME
    Transplant Cell Ther; 2023 May; 29(5):338.e1-338.e6. PubMed ID: 36775201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
    de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1152-1162. PubMed ID: 29505821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.